CNBX Pharmaceuticals Inc. (CNBX) Change in Cash (2013 - 2026)

CNBX Pharmaceuticals (CNBX) has 14 years of Change in Cash data on file, last reported at -$2667.0 in Q2 2026.

• Quarterly Change in Cash rose 91.67% year-over-year to -$2667.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was -$4161.0 (up 93.04% YoY) and the FY2025 annual result came in at -$11305.0, up 89.05% from the prior year.
• Change in Cash slipped to -$2667.0 in Q2 2026, from $4451.0 in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $85545.0 in Q3 2023 to a low of -$554777.0 in Q1 2022.
• A 5-year average of -$42893.1 and a median of -$5502.5 in 2023 frame the typical range for Change in Cash.
• The widest YoY moves for Change in Cash: up 1108.17% in 2024, down 270.2% in 2024.
• Tracing CNBX's Change in Cash over 5 years: stood at -$95915.0 in 2022, then soared by 49.9% to -$48049.0 in 2023, then surged by 81.11% to -$9077.0 in 2024, then climbed by 18.39% to -$7408.0 in 2025, then surged by 64.0% to -$2667.0 in 2026.
• The last three Change in Cash figures came in at -$2667.0 (Q2 2026), $4451.0 (Q1 2026), and -$7408.0 (Q4 2025), per Business Quant data.